AJP - Lung Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 285: L1255-L1262, 2003. First published July 11, 2003; doi:10.1152/ajplung.00303.2002
1040-0605/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/L1255    most recent
00303.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segel, M. J.
Right arrow Articles by Breuer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segel, M. J.
Right arrow Articles by Breuer, R.

Role of interferon-{gamma} in the evolution of murine bleomycin lung fibrosis

Michael J. Segel,1 Gabriel Izbicki,1 Pazit Y. Cohen,1 Reuven Or,2 Thomas G. Christensen,3 Shulamit B. Wallach-Dayan,1 and Raphael Breuer1,3

1Lung Cellular & Molecular Biology Laboratory, Institute of Pulmonology, 2Bone Marrow Transplantation Department, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel; and 3Mallory Institute of Pathology, Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118

Submitted 14 September 2002 ; accepted in final form 27 June 2003

IFN-{gamma} production is upregulated in lung cells (LC) of bleomycin-treated C57BL/6 mice. The present study characterizes the time course, cellular source, and regulation of IFN-{gamma} expression in bleomycin-induced lung injury. IFN-{gamma} mRNA in LC from bleomycin-treated mice peaked 3 days after intratracheal instillation. IFN-{gamma} protein levels were increased at 6 days, as was the percentage of LC expressing IFN-{gamma}. CD4+, CD8+, and natural killer cells each contributed significantly to IFN-{gamma} production. IL-12 mRNA levels were increased at 1 day in LC of bleomycin-treated mice. Anti-IL-12 and anti-IL-18 antibodies decreased IFN-{gamma} production by these cells. To define the role of endogenous IFN-{gamma} in the evolution of bleomycin lung injury, we compared the effect of bleomycin in mice with a targeted knockout mutation of the IFN-{gamma} gene (IFN-{gamma} knockout) and wild-type mice. At 14 days after intratracheal bleomycin, total bronchoalveolar lavage cell counts and lung hydroxyproline were decreased in IFN-{gamma} knockouts compared with wild-type animals. There was no difference in morphometric parameters of fibrosis. Our data show that enhanced IFN-{gamma} production in the lungs of bleomycin-treated mice is at least partly IL-12 and IL-18 dependent. Absence of IFN-{gamma} in IFN-{gamma} knockout mice does not increase pulmonary fibrosis. Endogenous IFN-{gamma} may play a proinflammatory or profibrotic role in bleomycin-induced lung fibrosis.

interstitial lung disease; transgenic/knockout; cytokines



Address for reprint requests and other correspondence: R. Breuer, Inst. of Pulmonology, Hadassah Univ. Hospital, POB 12000, Jerusalem 91120, Israel (E-mail: raffi{at}hadassah.org.il).




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Moodley, D. Atienza, U. Manuelpillai, C. S. Samuel, J. Tchongue, S. Ilancheran, R. Boyd, and A. Trounson
Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
Am. J. Pathol., July 1, 2009; 175(1): 303 - 313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Golan-Gerstl, S. B. Wallach-Dayan, G. Amir, and R. Breuer
Epithelial Cell Apoptosis by Fas Ligand-Positive Myofibroblasts in Lung Fibrosis
Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Xu, A. L. Mora, J. LaVoy, K. L. Brigham, and M. Rojas
Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L658 - L667.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. L. Mora, C. R. Woods, A. Garcia, J. Xu, M. Rojas, S. H. Speck, J. Roman, K. L. Brigham, and A. A. Stecenko
Lung infection with {gamma}-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L711 - L721.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Yamada, H. Kubo, S. Kobayashi, K. Ishizawa, and H. Sasaki
Interferon-{gamma}: a key contributor to hyperoxia-induced lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1042 - L1047.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.